- Home
- AVGR vs TTNP Comparison
AVGR vs TTNP Comparison
Compare AVGR & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVGR
- TTNP
- Stock Information
- Founded
- AVGR 2007
- TTNP 1991
- Country
- AVGR United States
- TTNP United States
- Employees
- AVGR N/A
- TTNP N/A
- Industry
- AVGR Medical/Dental Instruments
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVGR Health Care
- TTNP Health Care
- Exchange
- AVGR Nasdaq
- TTNP Nasdaq
- Market Cap
- AVGR 2.6M
- TTNP 3.0M
- IPO Year
- AVGR 2015
- TTNP 1996
- Fundamental
- Price
- AVGR $0.56
- TTNP $3.25
- Analyst Decision
- AVGR Strong Buy
- TTNP
- Analyst Count
- AVGR 1
- TTNP 0
- Target Price
- AVGR $5.00
- TTNP N/A
- AVG Volume (30 Days)
- AVGR 877.5K
- TTNP 36.8K
- Earning Date
- AVGR 03-19-2025
- TTNP 03-31-2025
- Dividend Yield
- AVGR N/A
- TTNP N/A
- EPS Growth
- AVGR N/A
- TTNP N/A
- EPS
- AVGR N/A
- TTNP N/A
- Revenue
- AVGR $7,262,000.00
- TTNP N/A
- Revenue This Year
- AVGR N/A
- TTNP N/A
- Revenue Next Year
- AVGR $93.49
- TTNP N/A
- P/E Ratio
- AVGR N/A
- TTNP N/A
- Revenue Growth
- AVGR N/A
- TTNP N/A
- 52 Week Low
- AVGR $0.39
- TTNP $3.03
- 52 Week High
- AVGR $5.45
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- AVGR 43.82
- TTNP 46.75
- Support Level
- AVGR $0.50
- TTNP $3.17
- Resistance Level
- AVGR $0.65
- TTNP $3.50
- Average True Range (ATR)
- AVGR 0.06
- TTNP 0.32
- MACD
- AVGR 0.00
- TTNP -0.01
- Stochastic Oscillator
- AVGR 32.90
- TTNP 19.32
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.